Actelion Pharmaceuticals competitive analysis

Explore patent oppositions filed by Actelion Pharmaceuticals against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Aug 27, 2026
Patent NumberTitleApplicantOpposition Date
Therapeutic Agent For Chronic Renal FailureTORAY INDUSTRIESDec 3, 2015

Explore Actelion Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 27, 2026
Patent NumberPublication DateTitleTotal Oppositions
Sep 4, 2024Methods Of Treating Pulmonary Arterial Hypertension4
May 22, 2024Pharmaceutical Composition For The Treatment Of Pulmonary Arterial Hypertension3
Jan 26, 2022Dosing Regimen For A Selective S1P1 Receptor Agonist2
Apr 21, 2021Pharmaceutical Composition Comprising Selexipag1
Nov 13, 2019Dosing Regimen For A Selective Sip1 Receptor Agonist1
Oct 9, 2019Therapeutic Compositions Containing Macitentan3
Oct 25, 2017Therapeutic Compositions Containing Macitentan5
Nov 11, 2015Novel Epoprostenol Formulation And Method Of Making Thereof1

Latest PTAB cases involving Actelion Pharmaceuticals

Discover the latest PTAB cases involving Actelion Pharmaceuticals, highlighting their recent legal challenges and patent disputes.

Last updated on: Aug 28, 2026
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Actelion Pharmaceuticals

IPR2025-01139Jun 10, 2025UNITED THERAPEUTICSACTELION PHARMACEUTICALSDiscretionary Denial
IPR2015-00561Jan 13, 2015ACTELION PHARMACEUTICALSICOSFinal Written Decision
IPR2015-00562Jan 13, 2015ACTELION PHARMACEUTICALSICOSFinal Written Decision

Peer Comparison New

IP litigation analysis comparing Actelion Pharmaceuticals with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
ACTELION PHARMACEUTICALS12021
GENERICS UK319 - - -
HEXAL976 - -
ICOS - 1 - 8